GHRP-2
Also known as: ghrp2, growth hormone releasing peptide 2, KP-102, kp102, pralmorelin
Synthetic ghrelin analogue that potently stimulates GH release through the GHS-R receptor.
Quick Reference
GHRP-2 - Research Images
PSO vial render · Scientific images from Wikipedia · Tap to enlarge
Overview
Chemical compound
Pralmorelin is a growth hormone secretagogue (GHS) used as a diagnostic agent that is marketed by Kaken Pharmaceutical in Japan in a single-dose formulation for the assessment of growth hormone deficiency (GHD).
Mechanism of Action
Ghrelin receptor agonist with high GH pulse stimulation; mild hunger increase and cortisol/prolactin elevation at higher doses.
What Researchers Are Saying
Community Reports - Not Medical Advice
The following is aggregated from public forums, Reddit, and research communities. These are anecdotal reports from researchers only - not verified clinical data and not a recommendation of any kind.
GHRP-2 (also known as ghrp2, growth hormone releasing peptide 2) is studied within the growth hormone axis and body composition research community. Synthetic ghrelin analogue that potently stimulates GH release through the GHS-R receptor.
Last updated October 28, 2026
Research status: active. GHRP-2 appears across growth hormone axis and body composition research forums and academic literature. Researchers note this compound falls in the growth hormone category.
Last updated October 28, 2026
What Do You Think of This Peptide?
Share your opinion or research experience with GHRP-2. Comments are reviewed before appearing.